These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37106909)

  • 41. Streptococcus agalactiae infection kills red tilapia with chronic Francisella noatunensis infection more rapidly than the fish without the infection.
    Sirimanapong W; Thompson KD; Shinn AP; Adams A; Withyachumnarnkul B
    Fish Shellfish Immunol; 2018 Oct; 81():221-232. PubMed ID: 30017930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
    Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
    Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia.
    Wang J; He RZ; Lu GL; Luo HL; Lu DQ; Li AX
    Fish Shellfish Immunol; 2018 Nov; 82():522-530. PubMed ID: 30118846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory-controlled Challenges of Nile Tilapia (Oreochromis niloticus) with Streptococcus agalactiae: Comparisons between Immersion, Oral, Intracoelomic and Intramuscular Routes of Infection.
    Soto E; Zayas M; Tobar J; Illanes O; Yount S; Francis S; Dennis MM
    J Comp Pathol; 2016 Nov; 155(4):339-345. PubMed ID: 27817831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus).
    Pridgeon JW; Klesius PH
    Vaccine; 2011 Aug; 29(35):5986-93. PubMed ID: 21708205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining segments 9 and 10 in DNA and recombinant protein vaccines conferred superior protection against tilapia lake virus in hybrid red tilapia (
    Chamtim P; Suwan E; Dong HT; Sirisuay S; Areechon N; Wangkahart E; Hirono I; Mavichak R; Unajak S
    Front Immunol; 2022; 13():935480. PubMed ID: 35958595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A divalent DNA vaccine based on Sia10 and OmpU induces cross protection against Streptococcus iniae and Vibrio anguillarum in Japanese flounder.
    Sun Y; Zhang M; Liu CS; Qiu R; Sun L
    Fish Shellfish Immunol; 2012 Jun; 32(6):1216-22. PubMed ID: 22480661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of size and temperature at vaccination on immunization and protection conferred by a live attenuated Francisella noatunensis immersion vaccine in red hybrid tilapia.
    Soto E; Brown N; Gardenfors ZO; Yount S; Revan F; Francis S; Kearney MT; Camus A
    Fish Shellfish Immunol; 2014 Dec; 41(2):593-9. PubMed ID: 25462454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative detection of streptococcosis infection in dead samples of Nile Tilapia (Oreochromis niloticus).
    He RZ; Xu J; Wang J; Li AX
    J Appl Microbiol; 2020 Nov; 129(5):1157-1162. PubMed ID: 32396231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of elephant's foot (Elephantopus scaber) extract on growth performance, immune response, and disease resistance of nile tilapia (Oreochromis niloticus) fingerlings.
    Doan HV; Hoseinifar SH; Sringarm K; Jaturasitha S; Khamlor T; Dawood MAO; Esteban MÁ; Soltani M; Musthafa MS
    Fish Shellfish Immunol; 2019 Oct; 93():328-335. PubMed ID: 31344457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel development of cationic surfactant-based mucoadhesive nanovaccine for direct immersion vaccination against Francisella noatunensis subsp. orientalis in red tilapia (Oreochromis sp.).
    Thangsunan P; Kitiyodom S; Srisapoome P; Pirarat N; Yata T; Thangsunan P; Boonrungsiman S; Bunnoy A; Rodkhum C
    Fish Shellfish Immunol; 2022 Aug; 127():1051-1060. PubMed ID: 35872335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of three host-associated Bacillus species on mucosal immunity and gut health of Nile tilapia, Oreochromis niloticus and its resistance against Aeromonas hydrophila infection.
    Kuebutornye FKA; Wang Z; Lu Y; Abarike ED; Sakyi ME; Li Y; Xie CX; Hlordzi V
    Fish Shellfish Immunol; 2020 Feb; 97():83-95. PubMed ID: 31846773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune responses induced by inactivated vaccine against Aeromonas hydrophila in pacu, Piaractus mesopotamicus.
    Vaz Farias TH; Arijo S; Medina A; Pala G; da Rosa Prado EJ; Montassier HJ; Pilarski F; Antonio de Andrade Belo M
    Fish Shellfish Immunol; 2020 Jun; 101():186-191. PubMed ID: 32247044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory-controlled challenges of streptococcosis in Nile tilapia using the oral route (infected-feed) for infection.
    Owatari MS; Cardoso L; Pereira SA; Pereira UP; Tachibana L; Martins ML; Mouriño JLP
    Fish Shellfish Immunol; 2022 Jan; 120():295-303. PubMed ID: 34871760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-treatment of Nile tilapia (Oreochromis niloticus) with ozone nanobubbles improve efficacy of heat-killed Streptococcus agalactiae immersion vaccine.
    Linh NV; Dien LT; Sangpo P; Senapin S; Thapinta A; Panphut W; St-Hilaire S; Rodkhum C; Dong HT
    Fish Shellfish Immunol; 2022 Apr; 123():229-237. PubMed ID: 35288305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential of mucoadhesive polymer in enhancing efficacy of direct immersion vaccination against Flavobacterium columnare infection in tilapia.
    Kitiyodom S; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N; Yata T
    Fish Shellfish Immunol; 2019 Mar; 86():635-640. PubMed ID: 30528659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laboratory and Field Assessments of Oral
    Mohamad A; Mursidi FA; Zamri-Saad M; Amal MNA; Annas S; Monir MS; Loqman M; Hairudin F; Al-Saari N; Ina-Salwany MY
    Animals (Basel); 2022 Jan; 12(2):. PubMed ID: 35049757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
    Pasnik DJ; Evans JJ; Klesius PH
    Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune Activation Following Vaccination of
    Tanpichai P; Chaweepack S; Senapin S; Piamsomboon P; Wongtavatchai J
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The growth performance, antioxidant capacity, immunological responses, and the resistance against Aeromonas hydrophila in Nile tilapia (Oreochromis niloticus) fed Pistacia vera hulls derived polysaccharide.
    Mohammadi G; Rafiee G; El Basuini MF; Abdel-Latif HMR; Dawood MAO
    Fish Shellfish Immunol; 2020 Nov; 106():36-43. PubMed ID: 32739534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.